Xtant Medical (XTNT) Director Abhinav Jain Receives 215,517-Share Award

What Happened Abhinav Jain, a director of Xtant Medical Holdings, Inc. (XTNT), was granted 215,517 deferred stock units (DSUs) on August 15, 2026. The units were reported as acquired at $0.00 (no cash paid). These DSUs will vest on August 15, 2027, conditioned on Jain remaining a director; settlement of vested shares is deferred to a later date. Each DSU represents a contingent right to receive one share of the company’s common stock.

Key Details

• Transaction date: 2026-08-15; Filing date: 2026-08-18 (three days after the transaction).
• Grant: 215,517 DSUs @ $0.00 (total reported value $0 on grant).
• Vesting/settlement: Vest on 2027-08-15 if the reporting person remains a director; settlement of vested shares will occur later per the DSU agreement.
• Reported DSU holdings: Filing notes 373,745 shares issuable upon settlement of DSUs granted under the 2023 Equity Incentive Plan (per footnote), which are conditioned on continued service through respective vesting dates.
• Footnotes: F1 explains the grant is a DSU award with vesting and deferred settlement; F2 notes the 373,745 shares issuable upon settlement of previously granted DSUs.
• Timeliness: Filing was dated Aug 18, 2026; Form 4s are generally due within two business days of the transaction — the filing date is provided here for your review.

Context This transaction is an equity award (compensation) to a director rather than an open-market buy or sell. DSU grants are common for non-employee directors and do not represent an immediate cash investment or sale; they are contingent on continued service and later settlement.